A Phase Ib, Open-Label, Dose-Finding Study Of Ruxolitinib In Patients (Pts) With Primary Myelofibrosis (Pmf), Post-Polycythemia Vera-Myelofibrosis (Ppv-Mf), Or Post-Essential Thrombocythemia-Myelofibrosis (Pet-Mf) And Baseline Platelets (Plts) 50 To < 100 X 10(9)/L
JOURNAL OF CLINICAL ONCOLOGY(2012)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined